Koers Q BioMed Inc. Other OTC
Aandelen
QBIO
US74736N1054
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 0,2 0,18 | Omzet 2022 | 0,28 0,27 | Marktkapitalisatie | 1,35 mln. 1,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -8 mln. -7,48 mln. | Nettowinst (verlies) 2022 | -2 mln. -1,87 mln. | EV/omzet 2021 | 79.967.019 x |
Nettoschuld 2021 | 2,71 mln. 2,53 mln. | Nettoschuld 2022 | 4,06 mln. 3,8 mln. | EV/omzet 2022 | 19.023.098 x |
K/w-verhouding 2021 |
-1,39
x | K/w-verhouding 2022 |
-0,2
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 97,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Denis Corin
CEO | Chief Executive Officer | 51 | 21-04-15 |
Ari Jatwes
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 55 | 01-06-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 55 | 01-06-15 | |
Denis Corin
CEO | Chief Executive Officer | 51 | 21-04-15 |
Rick Panicucci
BRD | Director/Board Member | 63 | 13-02-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,13% | 122 mld. | |
+19,65% | 113 mld. | |
+20,76% | 26,49 mld. | |
-23,84% | 19,4 mld. | |
-17,80% | 16,24 mld. | |
-45,95% | 15,15 mld. | |
-19,28% | 15,4 mld. | |
+63,81% | 14,93 mld. | |
+1,94% | 13,52 mld. |